News & Events
Chapel-en-le-Frith, UK, 5th March 2008
PEAKDALE MOLECULAR STRENGTHENS MANAGEMENT TEAM
Peakdale Molecular, the chemistry development and medicinal chemistry company announces it has appointed Dr. Paul Doyle
as its Director of Technology.
Paul brings more than 25 years knowledge of drug discovery and technology to Peakdale Molecular, with experience across most therapeutic areas.
Paul was most recently Technical Director at BioFocus (now BioFocus DPI, a Galapagos company) where between 1997 and 2003, he was a founding scientist and Director of Chemistry.
From 1981 to 1996, he held a variety of senior positions in research for the Wellcome Foundation at Beckenham in Kent, culminating in Senior Research Scientist for the Drug Discovery Unit.
Paul holds a degree in chemistry from New College, Oxford and achieved his D.Phil. at the University of Sussex in 1981. He has previously been Secretary to the UK Peptide and Protein Group and was one of the instigators of the BioMolecular Structure Unit at the University of Sussex.
Dr. Ray Fisher, CEO of Peakdale commented: “Paul’s experience and proven track record in providing Modern Medicinal Chemical solutions to the drug discovery and development programs of emerging BioPharma make him a strategic recruitment and reinforces Peakdale’s ambitions in this arena.”
About Peakdale Molecular
Peakdale Molecular was founded in 1992. Today, the Company's customers include the majority of the major global pharmaceutical companies and an increasing number of biotechnology companies. Its teams of chemists combine experience in pharmaceutical R&D and process development, medicinal chemistry, parallel synthesis and fine chemicals to deliver unique chemistry solutions to a range of drug discovery challenges.
The application of less commonly used chemistry, including high temperature/pressure reactions, proprietary heterocyclic chemistry and nucleoside synthesis, enables Peakdale's chemists to generate unique compounds for drug discovery. Peakdale operates in several distinct markets providing novel screening compounds, targeted screening libraries, catalogue intermediates, custom synthesis and contract research. Further information about the Company can be obtained at www.peakdale.com
Peakdale Molecular Ltd
Paul Doyle, Director of Technology
Peakdale Molecular Ltd
Peakdale Science Park
Sheffield Road
Chapel-en-le-Frith
High Peak
SK23 0PG
Tel +44 (0) 1298 816700
Fax +44 (0) 1298 816701
Email paul.doyle@peakdale.co.uk